Abound Wealth Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184 Hold
20
﹤0.01% 1130
2026
Q1
$217 Hold
20
﹤0.01% 1216
2025
Q4
$123 Hold
20
﹤0.01% 1346
2025
Q3
$104 Hold
20
﹤0.01% 1303
2025
Q2
$119 Hold
20
﹤0.01% 1211
2025
Q1
$165 Sell
20
-5
-20% -$42 ﹤0.01% 1060
2024
Q4
$207 Hold
25
﹤0.01% 1053
2024
Q3
$192 Sell
25
-3
-11% -$28 ﹤0.01% 1189
2024
Q2
$291 Hold
28
﹤0.01% 994
2024
Q1
$335 Hold
28
﹤0.01% 1081
2023
Q4
$303 Sell
28
-17
-38% -$207 ﹤0.01% 1156
2023
Q3
$623 Buy
+45
New +$658 ﹤0.01% 767

Other funds holding PTEN

Abound Wealth Management's PTEN Position: Q2 2026 in Review

Abound Wealth Management held its Patterson-UTI (PTEN) position steady in Q2 2026 at 20 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #1130.

Abound Wealth Management first reported a position in PTEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $623 in Q3 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Abound Wealth Management held 20 shares of Patterson-UTI worth $184 as of Q2 2026.
  • Abound Wealth Management left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1130 holding.
  • Abound Wealth Management first reported a position in Patterson-UTI in Q3 2023 and has held it in 12 quarters since.
  • Abound Wealth Management's Patterson-UTI position peaked at $623 in Q3 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.